GlassScriptPhysician profile
Benjamin R Ciske
NPI 1104245851
$5,496.07
in general payments reported to CMS, 2019-2025
29 companies · $728 in 2025
The $728 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.27 · 2020: $832 · 2021: $152 · 2022: $608 · 2023: $583 · 2024: $2,516 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698 · Travel and Lodging: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,697.55 |
| Travel and Lodging | $1,129.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,740.17 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $492.68 | 2022-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $420.85 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $310.84 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $271.26 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $168.75 | 2021-2025 | Triclip, Nc Trek Neo, Cardiomems |
| Penumbra, INC. | $148.17 | 2024 | Indigo System |
| Amgen INC. | $125.31 | 2022-2025 | Repatha, Repatha |
| Abiomed | $112.50 | 2023-2025 | Impella |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Siemens Medical Solutions USA, INC. | $73.69 | 2022 | |
| Cvrx, INC. | $65.76 | 2022 | |
| Pfizer INC. | $54.70 | 2022-2025 | |
| Amarin Pharma, INC. | $47.21 | 2021-2022 | |
| Medtronic, INC. | $38.52 | 2021-2024 | In.Pact Admiral |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $37.14 | 2023 | Kcentra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.48 | 2022-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $32.94 | 2022-2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $30.30 | 2021-2022 | |
| Becton, Dickinson and Company | $28.82 | 2025 | Rotarexs 6 F X 135 Cm |
| Alnylam Pharmaceuticals INC. | $26.78 | 2023 | Onpattro |
| Daiichi Sankyo INC. | $24.90 | 2024 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $24.78 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $24.22 | 2021-2023 | Farxiga |
| Stryker Corporation | $23.00 | 2025 | Artix Mt |
| Teleflex LLC | $18.00 | 2025 | D-Stat |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2022 | |
| G Medical Diagnostic Services, INC. | $13.94 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.60 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Ciske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.